CClinicalTrials.gg
Status unknownNCT03340259Updated Nov 13, 2017

Intestinal Colonization in Newborn Infants With Enterostomy

An observational study in Newborn Infants With Enterostomy by Congenital Malformations of the Gastrointestinal Tract, Necrotizing Enterocolitis and Spontaneous Intestinal Perforation, sponsored by Universidade do Porto. Status unknown at 1 site in Portugal. Per ClinicalTrials.gov, last updated 2017-11-13.

Sponsored by Universidade do Porto · Observational

The sponsor has not verified this record recently (last verified Jul 2017), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
30
Sex
All
01

Study summary

The human microbiota, a collection of microorganisms mostly settled in the gastrointestinal tract, plays a major role in the maintenance of the hosts' health and in development of disease as well. Exposure to different conditions early in life contributes to distinct "pioneer" bacterial communities, which shape the newborn infants' development and influence their later physiological, immunological and neurological homeostasis. Newborn infants with congenital malformations of the gastrointestinal tract (CMGIT), necrotizing enterocolitis (NEC), and spontaneous intestinal perforation (SIP) commonly require abdominal surgery and enterostomy. While intestinal microbiota has been extensively studied in infants with anatomically uninterrupted intestine, the knowledge of longitudinal intestinal colonization in this population is scarce.

This is an exploratory, observational, and longitudinal prospective study, primarily aimed to determine longitudinally the colonization of the proximal remnant intestine, in newborn infants with enterostomy after surgery (three weeks) for CMGIT, NEC and SIP. The secondary aim is to explore the associations of the colonization with the mode of delivery, gestational age, postnatal age, duration of fasting, type of enteric feeding, antimicrobial therapy, H2-receptor antagonist therapy, and length of proximal remnant intestine.

02

Conditions studied

  • Newborn Infants With Enterostomy by Congenital Malformations of the Gastrointestinal Tract, Necrotizing Enterocolitis and Spontaneous Intestinal Perforation

Keywords

  • Congenital malformations of the gastrointestinal tract
  • Enterostomy
  • Microbiota
  • Necrotizing enterocolitis
  • Newborn Infants
  • Spontaneous intestinal perforation
03

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Newborn infants with enterostomy after surgery for CMGIT, NEC or SIP recruited at the NICU of Hospital Dona Estefânia, Centro Hospitalar de Lisboa Central, Lisbon, Portugal.

Eligibility criteria

Inclusion criteria: newborn infants with enterostomy after surgery for CMGIT, NEC or SIP, consecutively admitted

Exclusion criteria: newborn infants with diagnosed inborn errors of metabolism, those whose parents or legal guardians will not consent to participate or withdrawn the consent, and those who had not complete 21 days of follow-up.

04

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
30 participants (estimated)
Patient registry
No
Biospecimen retention
Samples with dna

Groups and cohorts

  • Newborn infants with enterostomy

    Infants with enterostomy after surgery due to congenital malformations of the gastrointestinal tract, necrotizing enterocolitis, and spontaneous intestinal perforation

    Procedure: Exposure(s) of interest: enterostomy

Interventions

  • ProcedureExposure(s) of interest: enterostomy

    Newborn infants with congenital malformations of the gastrointestinal tract, necrotizing enterocolitis, and spontaneous intestinal perforation commonly require surgery and enterostomy. In these infants samples of the enterostomy effluent will be collected and DNA extracted for microbiota identification.

05

What researchers measure

Primary outcomes

  1. Pattern of postsurgical intestinal microbiota colonization specific to each underlying condition

    Longitudinal postsurgical microbiota colonization of the proximal remnant intestine, specific to each underlying condition

    Time frame: The first sample will be collected as close as possible after placement of ostomy bag. From the first collection, new samples will be collected every 3 days, until the 21st day after surgery

Secondary outcomes

  1. Associations of types of microorganism identified with below defined clinical variables

    Associations of microbiota colonization with the mode of delivery, gestational age, postnatal age, duration of fasting, type of enteric feeding, antimicrobial therapy, H2-receptor antagonist therapy, and length of proximal remnant intestine.

    Time frame: The aforementioned clinical variables will be collected daily and the enterostomy effluent collected from the first placement of ostomy bag and every 3 days thereafter up to 21 days after surgery

06

Study locations

1 of 1 sites recruiting
  • Neonatal Intensive Care Unit, Hospital Dona Estefânia, Centro Hospitalar de Lisboa Central
    Lisbon, 1169-045, Portugal
    • Luís Pereira-da-Silva, MD, PhD · Contact · l.pereira.silva@nms.unl.pt · +351 917235528
    • Inês B Mota, Student · Contact · ines.mota@nms.unl.pt · +351 218 803 000
    • Conceição Calhau, PhD · Principal investigator
    • Luís Pereira-da-Silva, MD, PhD · Principal investigator
    • Maria T Neto, MD, PhD · Sub investigator
    • Gonçalo, C Ferreira, MD · Sub investigator
    • Daniel Virella, MD, MSc · Sub investigator
    • Ana Pita, MD · Sub investigator
    • Ana Faria, PhD · Sub investigator
    • Cláudia Marques, BsC · Sub investigator
    • Inês B Mota, BsC · Sub investigator
    Recruiting
07

References and documents

Publications

  • Barreiros Mota I, Marques C, Faria A, Neto MT, Cordeiro-Ferreira G, Virella D, Pita A, Pereira-da-Silva L, Calhau C. Colonisation of the proximal intestinal remnant in newborn infants with enterostomy: a longitudinal study protocol. BMJ Open. 2019 Nov 24;9(11):e028916. doi: 10.1136/bmjopen-2019-028916. PubMed 31767579 ↗

Individual participant data

Plan to share: No

08

Registry details

Key details

Study ID
NCT03340259
Lead sponsor
Universidade do Porto
Collaborators
CINTESIS - Center for Health Technology and Services Research, Porto, Hospital Dona Estefânia, Centro Hospitalar de Lisboa Central, Lisboa, Universidade Nova de Lisboa
Responsible party
Sponsor
First posted
Nov 13, 2017
Start date
Jun 21, 2017
Primary completion
Jun 2020 (estimated)
Completion
Jun 2020 (estimated)
Last update
Nov 13, 2017

Study contacts

Luís Pereira-da-Silva, MD, PhD
Contact
l.pereira.silva@nms.unl.pt
+351 917235528
Conceição Calhau, PhD
Contact
ccalhau@nms.unl.pt
+351 218803000
Luís Pereira-da-Silva, MD, PhD
principal investigator · Hospital Dona Estefânia, Centro Hospitalar de Lisboa Central
Conceição Calhau, PhD
principal investigator · Universidade Nova de Lisboa

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jul 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion